Cargando…

COVID-19 and ischemic stroke: Mechanisms of hypercoagulability (Review)

During the coronavirus disease 2019 (COVID-19) pandemic, some patients with severe COVID-19 exhibited complications such as acute ischemic stroke (AIS), which was closely associated with a poor prognosis. These patients often had an abnormal coagulation, namely, elevated levels of D-dimer and fibrin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shuoqi, Zhang, Jinming, Wang, Chunxu, Chen, Xiaojing, Zhao, Xinyi, Jing, Haijiao, Liu, Huan, Li, Zhuxin, Wang, Lihua, Shi, Jialan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849983/ https://www.ncbi.nlm.nih.gov/pubmed/33448315 http://dx.doi.org/10.3892/ijmm.2021.4854

Ejemplares similares

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors
por: Xiang, Mengqi, et al.
Publicado: (2022)

Correlation Between Hypercoagulable State and Severity Level of Ischemic Stroke With Covid-19 Infection
por: Amalia, Lisda
Publicado: (2023)

The Central Role of Extracellular Vesicles in the Mechanisms of Thrombosis in COVID-19 Patients With Cancer and Therapeutic Strategies
por: Jing, Haijiao, et al.
Publicado: (2022)

Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded
por: Finsterer, J., et al.
Publicado: (2020)

Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded
por: Elkhider, Hisham, et al.
Publicado: (2020)

Utility of Thromboelastography to Identify Hypercoagulability in Lung Cancer Related Ischemic Stroke Patients
por: Quan, Xuemei, et al.
Publicado: (2020)

Pathophysiological mechanisms of thrombosis in acute and long COVID-19
por: Jing, Haijiao, et al.
Publicado: (2022)

Endothelial damage and a thin intercellular fibrin network promote haemorrhage in acute promyelocytic leukaemia
por: Wang, Chunxu, et al.
Publicado: (2020)

Persistent Lung Injury and Prothrombotic State in Long COVID
por: Xiang, Mengqi, et al.
Publicado: (2022)

Ischemic lesions in all territories as a marker of malignant hypercoagulability
por: Simonsen, Claus Z., et al.
Publicado: (2019)

Damage to endothelial barriers and its contribution to long COVID
por: Wu, Xiaoming, et al.
Publicado: (2023)

Potential Mechanisms of Cancer-Related Hypercoagulability
por: Nasser, Nicola J., et al.
Publicado: (2020)

The Burden of Hypercoagulability in COVID-19
por: Kim, Madeleine, et al.
Publicado: (2022)

Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020)

Biomarkers of Hypercoagulability in COVID-19
por: Wada, Hideo
Publicado: (2023)

The intersection of obesity and (long) COVID-19: Hypoxia, thrombotic inflammation, and vascular endothelial injury
por: Xiang, Mengqi, et al.
Publicado: (2023)

COVID-19 With Preexisting Hypercoagulability Digestive Disease
por: Jiang, Mingshan, et al.
Publicado: (2021)

Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
por: Wang, Chengyue, et al.
Publicado: (2022)

Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)
por: Zhao, Yunfei, et al.
Publicado: (2022)

The cross-talk of lung and heart complications in COVID-19: Endothelial cells dysfunction, thrombosis, and treatment
por: Liu, Langjiao, et al.
Publicado: (2022)

COVID-19 and Hypercoagulability: A Review
por: Kichloo, Asim, et al.
Publicado: (2020)

COVID-19 versus HIT hypercoagulability
por: Warkentin, Theodore E., et al.
Publicado: (2020)

Current Overview on Hypercoagulability in COVID-19
por: Singhania, Namrata, et al.
Publicado: (2020)

COVID-19 and hypercoagulability in the outpatient setting
por: Emert, Roger, et al.
Publicado: (2020)

CD44–fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition
por: Wang, Chunxu, et al.
Publicado: (2022)

Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021
por: Bo, Chunrui, et al.
Publicado: (2022)

A Hypercoagulable Hematological Metastasis Breast Cancer Model
por: Yang, Wen-Jing, et al.
Publicado: (2021)

Regulatory T cells in ischemic stroke
por: Wang, Huan, et al.
Publicado: (2021)

Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis
por: Wu, Xiaoming, et al.
Publicado: (2022)

Ischemic Stroke: An Underestimated Complication of COVID-19
por: Cao, Wen, et al.
Publicado: (2021)

Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study
por: Lee, Mi Ji, et al.
Publicado: (2017)

Hypercoagulability in Dogs with Blastomycosis
por: McMichael, M.A., et al.
Publicado: (2015)

Pernio during the COVID-19 pandemic and review of inflammation patterns and mechanisms of hypercoagulability
por: Cavanagh, Gregory, et al.
Publicado: (2020)

Hypercoagulability in COVID-19: A review of the potential mechanisms underlying clotting disorders
por: Alam, Walid
Publicado: (2021)

The Role of Anticoagulation in COVID-19-Induced Hypercoagulability
por: Rico-Mesa, Juan Simon, et al.
Publicado: (2020)

Thrombotic and Hypercoagulability Complications of COVID-19: An Update
por: Shibeeb, Sapha, et al.
Publicado: (2021)

HYPERCOAGULABLE STATE: AN ENIGMA IN COVID-19 INFECTION
por: MILI, SAIMA, et al.
Publicado: (2021)

COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
por: Sanfilippo, Filippo, et al.
Publicado: (2021)

Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis
por: Jing, Haijiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ia9vu72ta8l1jk4v01cplntpfb